Monthly Archives: February 2013

Targeted Medical Pharma is Assigned Comprehensive Pharmaceutical Billing Patent

Los Angeles, February 12, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced it has been issued patent number 8370172 from the United States Patent and Trademark Office. This is the company’s seventh patent and relates to a system and method for electronically submitting medication claims by point-of-care physicians. The patent officially was issued on February 5, 2013. “The issuance of this billing patent creates an opportunity for Continue reading →

Targeted Medical Pharma to Present at FutureMed

One-Day Event Explores Future of Health, Technology and Medicine Los Angeles, February 6th, 2013, Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, will demonstrate its amino acid-based medications at “FutureMed: Exploring the Future of Health, Technology & Medicine,” a symposium held this Saturday at the Computer History Museum in Mountain View, Calif. The conference brings together clinicians, entrepreneurs, investors and healthcare executives to accelerate a better future for health, wellness, diagnostics Continue reading →